Literature DB >> 31632820

Emphysema assessment for personalized immunotherapy response prediction in lung cancer patients.

Dimitra Kerdidani1, Sophia Magkouta2, Maria Tsoumakidou1.   

Abstract

Entities:  

Year:  2019        PMID： 31632820      PMCID： PMC6783793          DOI： 10.21037/jtd.2019.08.98

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  10 in total

1.  Immunoescape the link between emphysema and lung cancer?

Authors:  Jaume Sauleda; Francisco Javier Verdú; Sergio Scrimini; Ernest Sala; Jaume Pons
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

2.  Dysregulation of Antiviral Function of CD8(+) T Cells in the Chronic Obstructive Pulmonary Disease Lung. Role of the PD-1-PD-L1 Axis.

Authors:  Richard T McKendry; C Mirella Spalluto; Hannah Burke; Ben Nicholas; Doriana Cellura; Aymen Al-Shamkhani; Karl J Staples; Tom M A Wilkinson
Journal:  Am J Respir Crit Care Med       Date:  2016-03-15       Impact factor: 21.405

3.  Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade.

Authors:  Jérôme Biton; Hanane Ouakrim; Agnès Dechartres; Marco Alifano; Audrey Mansuet-Lupo; Han Si; Rebecca Halpin; Todd Creasy; Claudie Bantsimba-Malanda; Jennifer Arrondeau; François Goldwasser; Pascaline Boudou-Rouquette; Ludovic Fournel; Nicolas Roche; Pierre-Régis Burgel; Jeremy Goc; Priyanka Devi-Marulkar; Claire Germain; Marie-Caroline Dieu-Nosjean; Isabelle Cremer; Ronald Herbst; Diane Damotte
Journal:  Am J Respir Crit Care Med       Date:  2018-10-01       Impact factor: 21.405

4.  Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer.

Authors:  Nicholas M Mark; Julia Kargl; Stephanie E Busch; Grace H Y Yang; Heather E Metz; Huajia Zhang; Jesse J Hubbard; Sudhakar N J Pipavath; David K Madtes; A McGarry Houghton
Journal:  Am J Respir Crit Care Med       Date:  2018-02-01       Impact factor: 21.405

5.  Inhaled corticosteroids and the risk of lung cancer in COPD: a population-based cohort study.

Authors:  Adam J N Raymakers; Mohsen Sadatsafavi; Don D Sin; J Mark FitzGerald; Carlo A Marra; Larry D Lynd
Journal:  Eur Respir J       Date:  2019-06-05       Impact factor: 16.671

6.  The effect of radiographic emphysema in assessing lung cancer risk.

Authors:  Patrick C Yong; Keith Sigel; Juan Pablo de-Torres; Grace Mhango; Minal Kale; Chung Yin Kong; Javier J Zulueta; David Wilson; Stacey-Ann Whittaker Brown; Christopher Slatore; Juan Wisnivesky
Journal:  Thorax       Date:  2019-02-05       Impact factor: 9.139

7.  Cigarette Smoke-Induced Emphysema Exhausts Early Cytotoxic CD8+ T Cell Responses against Nascent Lung Cancer Cells.

Authors:  Dimitra Kerdidani; Sophia Magkouta; Panagiotis Chouvardas; Vassiliki Karavana; Konstantinos Glynos; Fani Roumelioti; Spyros Zakynthinos; Els Wauters; Wim Janssens; Diether Lambrechts; George Kollias; Maria Tsoumakidou
Journal:  J Immunol       Date:  2018-07-23       Impact factor: 5.422

8.  IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.

Authors:  Mauricio S Caetano; Huiyuan Zhang; Amber M Cumpian; Lei Gong; Nese Unver; Edwin J Ostrin; Soudabeh Daliri; Seon Hee Chang; Cesar E Ochoa; Samir Hanash; Carmen Behrens; Ignacio I Wistuba; Cinthya Sternberg; Humam Kadara; Carlos Gil Ferreira; Stephanie S Watowich; Seyed Javad Moghaddam
Journal:  Cancer Res       Date:  2016-04-01       Impact factor: 12.701

9.  Understanding the mechanisms of immune-evasion by lung cancer in the context of chronic inflammation in emphysema.

Authors:  Ramin Salehi-Rad; Steven M Dubinett
Journal:  J Thorac Dis       Date:  2019-02       Impact factor: 3.005

10.  Prognostic value of smoking status in non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis.

Authors:  Jung Han Kim; Hyeong Su Kim; Bum Jun Kim
Journal:  Oncotarget       Date:  2017-06-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.